INSIGHTS ON CLINICAL TRIAL PARTNERING
-
We Mapped What Sites Actually Do To Prepare Source Docs - The Results Are Eye-Opening
New global research shows how sites prepare source documents, where inefficiencies occur, and why workflows differ — highlighting ways to streamline processes, cut delays, and improve data quality.
-
AI-Powered Strategy Is Redefining Patient Recruitment Performance
This AI-powered platform is helping CROs and sponsors tackle the unsolved challenge they've faced for decades: clinical trials that launch late, recruit slowly, and miss enrollment targets.
-
Overcoming Site Challenges In Rare Disease Clinical Trials
Rare disease trials demand specialized site support. Explore how tailored site management practices can improve consistency, data quality, and patient engagement in complex clinical studies.
-
Expedite Drug Development With An Integrated CDMO-CRO Model
From optimizing first-in-human strategies to leveraging AI-enabled digital architectures, the integrated CDMO-CRO services model reduces risk and maximizes program value.
-
What The Suvoda-Greenphire Merger Means For Clinical Trials2/18/2026
Simplify the clinical trial journey by unifying logistics, data, and payments. Reduce administrative friction for sites and improve the patient experience to accelerate trial timelines.
-
Taking Research In-House With CRIO: SciTech's Multi-Center Phase 1 Study1/6/2025
Explore the success story of an early-stage clinical pharmaceutical company that effectively navigated funding constraints when conducting its Phase 1 study without a third-party CRO.
-
What If Therapeutic Area Expertise Isn't The Competitive Advantage We Think It Is?8/13/2026
Rethink vendor evaluation by looking beyond indication experience to discover how cross-trial adaptability, proactive risk management, and team judgment drive true clinical trial resilience.
-
Optimizing Site Activation To Accelerate Clinical Trials6/5/2025
Clinical trial site activation delays are a major bottleneck in drug development, hampering trial timelines and funding flows. To reverse this trend, site-focused solutions are being prioritized.
-
Autoinjectors For Autoimmune Diseases: Benefits And Considerations8/7/2025
By improving convenience, ensuring precise dosing, and reducing dependency on healthcare facilities, autoinjectors enhance patient outcomes and quality of life.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
Learn how your organization can become part of One Home for Sites, the only platform that’s bringing the industry together to help sites survive and thrive, along with their patients.
-
A new collaboration helps to remove obstacles from the critical path, reduce development risks, eliminate the white space in pre-clinical drug development, and shorten the pathway to clinical development.
-
Our turnkey operational infrastructure empowers sponsors and partners to execute trials more efficiently — reducing costs, accelerating timelines, and consistently delivering high-quality data.
-
Global Strategies to Align Your Goals With Regulatory Requirements
Ergomed’s regulatory consultancy services are guided by a team of seasoned consultants, each bringing a wealth of experience from regulatory agencies and in-house roles. This expertise ensures a proactive and flexible solution tailored to your project’s unique needs and timelines, instilling confidence in our services.
-
Our aim is to ensure the flawless and successful execution of clinical research, maximizing its impact on both patients and the commercial market.